Ph Buffers in the Blood
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Extracellular Volume in the Brain- the Relevance of the Chloride Space
Pediat. Res. 12: 635-645 (1978) A Review: Extracellular Volume in the Brain- The Relevance of the Chloride Space DONALD B. CHEEK(lZ2'AND A. BARRY HOLT Royal Children's Hospital Research Foundation, Parkville, Victoria, Australia By simultaneous infusion of anions into the blood and into the concerning brain water and the chloride space (C1 space) as a ventriculocisternal area it is possible to define two compart- measure of extracellular volume (ECV) . ments, one of blood plus brain and one of cerebrospinal fluid The rhesus monkey (Macaca mulatta) is a useful experimental (CSF) plus brain, with a zone of slow equilibration within the model. Comparisons of the macaque brain with the human brain brain where the two components meet. It would appear that during can prove rewarding. Our work on the growth of halogens (Br- and I-) have a much more remarkable and rapid the macaque brain and the distribution of C1- and H,O extends entrance into brain tissue from blood and, with increasing blood from midgestation (80 days) to term (165 days) and well into concentration, penetrate the second compartment significantly. the postnatal period (120 days after birth). The results of this Chloride is more strongly transported across the choroid plexus work have been documented in a recent publication (21). from blood to CSF (in comparison with I- or Br-). Chloride should resemble Br- and I- in diffusing rapidly through the intercellular canals back into the blood. However, knowledge I. CSF CIRCULATION AND ITS BARRIERS concerning C1- distribution dynamics is meager. The dynamics of chloride distribution, diffusion, and transport Homeostasis and the constancy of Claude Bernard's "Milieu using, for example, 36Cl-, 38Cl-, and stable C1-, have not been Interne" is essential for normal function of the central nervous studied sufficiently (in the two compartments), but circumstan- system (CNS). -
Pathophysiology of Acid Base Balance: the Theory Practice Relationship
Intensive and Critical Care Nursing (2008) 24, 28—40 ORIGINAL ARTICLE Pathophysiology of acid base balance: The theory practice relationship Sharon L. Edwards ∗ Buckinghamshire Chilterns University College, Chalfont Campus, Newland Park, Gorelands Lane, Chalfont St. Giles, Buckinghamshire HP8 4AD, United Kingdom Accepted 13 May 2007 KEYWORDS Summary There are many disorders/diseases that lead to changes in acid base Acid base balance; balance. These conditions are not rare or uncommon in clinical practice, but every- Arterial blood gases; day occurrences on the ward or in critical care. Conditions such as asthma, chronic Acidosis; obstructive pulmonary disease (bronchitis or emphasaemia), diabetic ketoacidosis, Alkalosis renal disease or failure, any type of shock (sepsis, anaphylaxsis, neurogenic, cardio- genic, hypovolaemia), stress or anxiety which can lead to hyperventilation, and some drugs (sedatives, opoids) leading to reduced ventilation. In addition, some symptoms of disease can cause vomiting and diarrhoea, which effects acid base balance. It is imperative that critical care nurses are aware of changes that occur in relation to altered physiology, leading to an understanding of the changes in patients’ condition that are observed, and why the administration of some immediate therapies such as oxygen is imperative. © 2007 Elsevier Ltd. All rights reserved. Introduction the essential concepts of acid base physiology is necessary so that quick and correct diagnosis can The implications for practice with regards to be determined and appropriate treatment imple- acid base physiology are separated into respi- mented. ratory acidosis and alkalosis, metabolic acidosis The homeostatic imbalances of acid base are and alkalosis, observed in patients with differing examined as the body attempts to maintain pH bal- aetiologies. -
Cyanide Remediation: Current and Past Technologies C.A
CYANIDE REMEDIATION: CURRENT AND PAST TECHNOLOGIES C.A. Young§ and T.S. Jordan, Department of Metallurgical Engineering, Montana Tech, Butte, MT 59701 ABSTRACT Cyanide (CN-) is a toxic species that is found predominantly in industrial effluents generated by metallurgical operations. Cyanide's strong affinity for metals makes it favorable as an agent for metal finishing and treatment and as a lixivant for metal leaching, particularly gold. These technologies are environmentally sound but require safeguards to prevent accidental spills from contaminating soils as well as surface and ground waters. Various methods of cyanide remediation by separation and oxidation are therefore reviewed. Reaction mechanisms are given throughout. The methods are compared in regard to their effectiveness in treating various cyanide species: free cyanide, thiocyanate, weak-acid dissociables and strong-acid dissociables. KEY WORDS cyanide, metal-cyanide complex, thiocyanate, oxidation, separation INTRODUCTION ent on the transport of these heavy metals through their tissues, cyanide is very toxic. Waste waters from industrial operations The mean lethal dose to the human adult is transport many chemicals that have ad- between 50 and 200 mg [2]. U.S. EPA verse effects on the environment. Various standards for drinking and aquatic-biota chemicals leach heavy metals which would waters regarding total cyanide are 200 and otherwise remain immobile. The chemicals 50 ppb, respectively, where total cyanide and heavy metals may be toxic and thus refers to free and metal-complexed cya- cause aquatic and land biota to sicken or nides [3]. According to RCRA, all cyanide species are considered to be acute haz- die. Most waste-water processing tech- ardous materials and have therefore been nologies that are currently available or are designated as P-Class hazardous wastes being developed emphasize the removal of when being disposed of. -
Acids and Bases
Name Date Class CHAPTER 14 REVIEW Acids and Bases SECTION 1 SHORT ANSWER Answer the following questions in the space provided. 1. Name the following compounds as acids: sulfuric acid a. H2SO4 sulfurous acid b. H2SO3 hydrosulfuric acid c. H2S perchloric acid d. HClO4 hydrocyanic acid e. hydrogen cyanide 2. H2S Which (if any) of the acids mentioned in item 1 are binary acids? 3. Write formulas for the following acids: HNO2 a. nitrous acid HBr b. hydrobromic acid H3PO4 c. phosphoric acid CH3COOH d. acetic acid HClO e. hypochlorous acid 4. Calcium selenate has the formula CaSeO4. H2SeO4 a. What is the formula for selenic acid? H2SeO3 b. What is the formula for selenous acid? 5. Use an activity series to identify two metals that will not generate hydrogen gas when treated with an acid. Choose from Cu, Ag, Au, Pt, Pd, or Hg. 6. Write balanced chemical equations for the following reactions of acids and bases: a. aluminum metal with dilute nitric acid ϩ → ϩ 2Al(s) 6HNO3(aq) 2Al(NO3)3(aq) 3H2(g) b. calcium hydroxide solution with acetic acid ϩ → ϩ Ca(OH)2(aq) 2CH3COOH(aq) Ca(CH3COO)2(aq) 2H2O(l ) MODERN CHEMISTRY ACIDS AND BASES 117 Copyright © by Holt, Rinehart and Winston. All rights reserved. Name Date Class SECTION 1 continued 7. Write net ionic equations that represent the following reactions: a. the ionization of HClO3 in water ϩ → ϩ ϩ Ϫ HClO3(aq) H2O(l ) H3O (aq) ClO3 (aq) b. NH3 functioning as an Arrhenius base ϩ → ϩ ϩ Ϫ NH3(aq) H2O(l ) ← NH4 (aq) OH (aq) 8. -
L7-Renal Regulation of Body Fluid [PDF]
Iden8fy and describe the role of the Sensors and Objectives Effectors in the Abbreviations renal regulaon of body fluid volume ADH An8diurec hormone & osmolality ECF Extracellular fluid ECV Effec8ve Circulang Iden8fy the site and Volume describe the Describe the role of ANF Atrial natriure8c factor influence of the kidney in aldosterone on regulaon of body ANP ATRIAL NATRIURETIC PEPTIDE reabsorp8on of Na+ fluid volume & in the late distal osmolality tubules. PCT Proximal convoluted tubules AVP arginine vasopressin Understand the role of ADH in the reabsorp8on of water and urea Mind map Blood volume remains exactly constant despite extreme changes in daily fluid intake and the reason for that is : 1- slight change in blood volume ! Renal regulaNon of marked change in Extra Cellular cardiac output Volume Is a reflex 2- a slight change mechanism in RegulaNon of ECF Thus, regulaon of in cardiac output which variables volume = Na+ also dependent !large change in reflecng total RegulaNon of body upon blood pressure body sodium and Na+= RegulaNon BP baroreceptors. 3-slight change in ECV are monitor by blood pressure ! appropriate sensor large change in (receptors) URINE OUTPUT . Con. Blood Volume regulation : Sensors Effectors Affecng 1- Rennin angiotensin, aldosterone. 1- Caro8d sinus Urinary Na excre8on. 2- ADH ( the result will cause a change in NA+ and water excre8on either 3- Renal sympathe8c nerve by increasing it or 2- Volume receptors decreasing it ) . (large vein, atria, intrarenalartery) 4- ANP Con. Blood Volume regulation : Cardiac atria Low pressure receptors Pulmonary vasculature Central vascular sensors Carod sinus Sensors in the CNS High pressure receptors AorNc arch Juxtaglomerular apparatus (renal afferent arteriole) Sensors in the liver ECF volume Receptors Con. -
Intravenous Fluid Therapy: a Review
INTRAVENOUS FLUID THERAPY: A REVIEW Joanne Gaffney, RN, CANP, MS If this common intervention isn’t managed vigilantly, it actually can exacerbate the risks it’s designed to alleviate. umerous conditions— In this article, I’ll review the ba- The body loses fluid through metabolic, infective, sics of fluid balance and the etiology such normal physiologic func- traumatic, and iatro- of fluid loss. I’ll discuss how to as- tions as breathing and urination. N genic—can cause fluid sess fluid depletion, outline the prin- But when certain diseases or en- depletion. In such cases, initiat- ciples of fluid replacement therapy, vironmental conditions substan- ing intravenous (IV) fluid replace- and explain the context in which tially increase fluid loss, the body ment is commonplace. In fact, IV various types of solutions are ad- may be unable to maintain ho- fluid replacement therapy is one ministered. I will not, however, meostasis, and fluid replacement of the most common invasive cover the treatment of diabetes mel- may be necessary. procedures hospitalized patients litus and diabetes insipidus, which undergo, and it’s performed in cer- follow different principles that are NORMAL FLUID LOSS tain outpatient and home care set- beyond the scope of this article. Normal fluid loss includes both in- tings as well. sensible and sensible losses. Each Fluid loss can put patients at FLUID MECHANICS day the skin loses approximately substantial risk for fluid and elec- Body water represents approxi- 300 mL and the lungs lose approxi- trolyte imbalances, which can lead mately 60% of a person’s total mately 700 mL of water from evap- to shock and multiple organ failure. -
Combining Sodium Bicarbonate and Lidocaine Injection
Combining Sodium Bicarbonate and Lidocaine injection Tom Simpleman Consultant Pharmacist the FAWKS company http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9c826a7‐8f19‐4857‐b5be‐11dcafcfc7a9 Referenced information from National Institutes of Health DESCRIPTION: Sodium Bicarbonate Inj., 8.4% USP Neutralizing Additive Solution is a sterile, nonpyrogenic, solution of sodium bicarbonate (NaHCO3) in Water for Injection. It is added to an appropriate local anesthetic as a neutralizing agent immediately prior to administration. The solution contains no bacteriostat, antimicrobial agent or added buffer and is intended only for single-use. pH is adjusted with carbon dioxide. Per the USP monograph for Sodium Bicarbonate Inj., pH is between 7.0 and 8.5. Osmolar concentration is 2 mOsmol/mL (calc.). Sodium bicarbonate, 84 mg is equal to one milliequivalent each of Na+ and HCO3-. Sodium Bicarbonate, USP is chemically designated as NaHC03, a white crystalline powder soluble in water. Sodium bicarbonate in water dissociates to provide sodium (Na+) and bicarbonate (HCO3-) ions. Sodium (Na+) is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. Bicarbonate (HCO3-) is a normal constituent of body fluids and the normal plasma level ranges from 24 to 31 mEq/liter. Bicarbonate anion is considered “labile” since at a proper concentration of hydrogen ion (H+) it may be converted to carbonic acid (H2CO3) and thence to its volatile form, carbon dioxide (CO2) excreted by the lung. Normally a ratio of 1:20 (carbonic acid; bicarbonate) is present in the extracellular fluid. In a healthy adult with normal kidney function, practically all the glomerular filtered bicarbonate ion is reabsorbed; less than 1% is excreted in the urine. -
Important Prescribing Information
Important Prescribing Information Subject: Temporary importation of 8.4% Sodium Bicarbonate Injection to address drug shortage issues June 14, 2019 Dear Healthcare Professional, Due to the current critical shortage of Sodium Bicarbonate Injection, USP in the United States (US) market, Athenex Pharmaceutical Division, LLC (Athenex) is coordinating with the U.S. Food and Drug Administration (FDA) to increase the availability of Sodium Bicarbonate Injection. Athenex has initiated temporary importation of another manufacturer’s 8.4% Sodium Bicarbonate Injection (1 mEq/mL) into the U.S. market. This product is manufactured and marketed in Australia by Phebra Pty Ltd (Phebra). At this time, no other entity except Athenex Pharmaceutical Division, LLC is authorized by the FDA to import or distribute Phebra’s 8.4% Sodium Bicarbonate Injection, (1 mEq/mL), 10 mL vials, in the United States. FDA has not approved Phebra’s 8.4% Sodium Bicarbonate Injection but does not object to its importation into the United States. Effective immediately, and during this temporary period, Athenex will offer the following presentation of Sodium Bicarbonate Injection: Sodium Bicarbonate Injection, 8.4% (1mEq/mL), 10mL per vial, 10 vials per carton Ingredients: sodium bicarbonate, water for injection, disodium edetate and sodium hydroxide (pH adjustment) Marketing Authorization Number in Australia is: 131067 Phebra’s Sodium Bicarbonate Injection contains the same active ingredient, Sodium Bicarbonate, in the same strength and concentration, 8.4% (1 mEq/mL) as the U.S. registered Sodium Bicarbonate Injection, USP by Pfizer’s subsidiary, Hospira. However, it is important to note that Phebra’s Sodium Bicarbonate Injection (1 mEq/mL), is provided only in a Single Use 10 mL vials, whereas Hospira’s product is provided in 50 mL single-dose vials and syringes. -
UNITED STATES PATENT OFFICE. ">Co
UNITED STATES PATENT OFFICE. LEONHARD LEDERER, OF MUNICH, GERMANY. PROCESS OF PRE PARNG HAO D DERVATIVES OF ACET ONE. SPECIFICATION forming part of Letters Patent No. 643,144, dated February 13, 1900. Application filed August 10, 1897, Serial No. 647,759. (No specimens.) To all livhon, it nay conce77: iodacetone. Also if not kept dry it some Beit known that I, LEONHARDLEDERER, a times undergoes decomposition at an ordi citizen of the Kingdom of Bavaria, residing nary temperature, thereby evolving so much SO at Munich, Bavaria, Germany, have invented heat that vapor of iodin is set free. Alco a new and useful Process of Preparing the hol, ether, and most of the organic solvents IIalogen Derivatives of Acetone, of which the set free iodin from per-iod-acetone. With following is a specification. dilute soda-lye it forms iodoform in the cold. 55 It is well known that the halogens act read The action of iodin on acetone-dicarbonic. ily upon acetonedicarbonic acid. For in acid can be so regulated by definite diminu stance, bromin added to an aqueous solution tions of the quantity of iodin added as to re of acetonedicarbonic acid is immediately sult in lower stages of iodin combination with taken up. An aqueous solution of acetonedi acetone. With regard to its behavior toward carbonic acid decomposed with an alcoholic alcohol and ether the penta-iod derivative is iodin solution takes up quickly the color of in close relation with the periodacetone. On the latter without visible reaction. If, how the addition of dilute soda-lye it is trans ever, this mixture be gently Warmed, reac formed into iodoform even in the cold, but tion takes place, evolving carbonic acid gas; not with the soda solution. -
Structure and Functioning of the Acid–Base System in the Baltic Sea
Earth Syst. Dynam., 8, 1107–1120, 2017 https://doi.org/10.5194/esd-8-1107-2017 © Author(s) 2017. This work is distributed under the Creative Commons Attribution 3.0 License. Structure and functioning of the acid–base system in the Baltic Sea Karol Kulinski´ 1, Bernd Schneider2, Beata Szymczycha1, and Marcin Stokowski1 1Institute of Oceanology, Polish Academy of Sciences, IO PAN, ul. Powstanców´ Warszawy 55, 81-712 Sopot, Poland 2Leibniz Institute for Baltic Sea Research Warnemünde, IOW, Seestrasse 15, 18119 Rostock, Germany Correspondence: Karol Kulinski´ ([email protected]) Received: 6 April 2017 – Discussion started: 12 April 2017 Revised: 21 October 2017 – Accepted: 6 November 2017 – Published: 11 December 2017 Abstract. The marine acid–base system is relatively well understood for oceanic waters. Its structure and func- tioning is less obvious for the coastal and shelf seas due to a number of regionally specific anomalies. In this review article we collect and integrate existing knowledge of the acid–base system in the Baltic Sea. Hydro- graphical and biogeochemical characteristics of the Baltic Sea, as manifested in horizontal and vertical salinity gradients, permanent stratification of the water column, eutrophication, high organic-matter concentrations and high anthropogenic pressure, make the acid–base system complex. In this study, we summarize the general knowledge of the marine acid–base system as well as describe the peculiarities identified and reported for the Baltic Sea specifically. In this context we discuss issues such as dissociation constants in brackish water, differ- ent chemical alkalinity models including contributions by organic acid–base systems, long-term changes in total alkalinity, anomalies of borate alkalinity, and the acid–base effects of biomass production and mineralization. -
Alternative Solvents for Catalysis and Organic Reactions
ALTERNATIVE SOLVENTS FOR CATALYSIS AND ORGANIC REACTIONS A Thesis Presented to The Academic Faculty By Vittoria Madonna Blasucci In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in Chemical & Biomolecular Engineering Georgia Institute of Technology December 2009 ALTERNATIVE SOLVENTS FOR CATALYSIS AND ORGANIC REACTIONS Dr. Charles A. Eckert, Advisor School of Chemical & Biomolecular Engineering Georgia Institute of Technology Dr. Charles L. Liotta, Co-Advisor School of Chemistry & Biochemistry Georgia Institute of Technology Dr. William Koros School of Chemical & Biomolecular Engineering Georgia Institute of Technology Dr. Christopher Jones School of Chemical & Biomolecular Engineering Georgia Institute of Technology Dr. Amyn Teja School of Chemical & Biomolecular Engineering Georgia Institute of Technology Date Approved: September 30th 2009 For my Mom and Dad- Without them I would have never made it through ACKNOWLEDGEMENTS First, I would like to acknowledge my advisor, Prof. Charles Eckert. Under his guidance, I was given the freedom to take my research into the areas that interest me the most. Not only is he a valuable information source, but he is also an excellent mentor. In addition, I thank my co-advisor, Prof. Charles Liotta. It has been my pleasure to work with someone who truly loves what they do and refreshing to see somebody who enjoys science so much. Due to these two professors, my time at Georgia Tech has been excellent. I greatly appreciate the time and advice of my committee members: Professors Amyn Teja, Bill Koros, and Chris Jones. Thank you for reading through and editing this document! I would also like to acknowledge Dr. -
Fluid, Electrolyte & Ph Balance
Fluid / Electrolyte / Acid-Base Balance Fluid, Electrolyte Body Fluids: & pH Balance Cell function depends not only on continuous nutrient supply / waste removal, but also on the physical / chemical homeostasis of surrounding fluids 1) Water: (universal solvent) Body water varies based on of age, sex, mass, and body composition H2O ~ 73% body weight Low body fat Low bone mass H2O (♂) ~ 60% body weight H2O (♀) ~ 50% body weight ♀ = body fat / muscle mass H2O ~ 45% body weight Fluid / Electrolyte / Acid-Base Balance Fluid / Electrolyte / Acid-Base Balance Body Fluids: Clinical Application: Cell function depends not only on continuous nutrient supply / waste removal, but also on the physical / chemical homeostasis of surrounding fluids The volumes of the body fluid compartments are measured by the dilution method 1) Water: (universal solvent) Total Body Water Step 1: Step 2: Step 4: Volume = 40 L (60% body weight) Identify appropriate marker Inject known volume of Calculate volume of body substance marker into individual fluid compartment Plasma Total Body Water: Amount Volume = A marker is placed in (L) Concentration the system that is distributed (mg) Intracellular Fluid (ICF) Interstitial wherever water is found Volume = 3 = 3 Volume Volume = 25 L Fluid Amount: Marker: D2O (40% body weight) Volume = 12 L Step 3: Amount of marker injected (mg) – Amount excreted (mg) L Extracellular Fluid Volume: Let marker equilibrate and A marker is placed in measure marker Concentration: the system that can not cross • Plasma concentration Concentration